Clinical Trials Directory

Trials / Completed

CompletedNCT00855569

Hemostatic Textile to Control Bleeding at Donor Graft Sites

Use of a HemostaticTextile (StasilonTM) to Control Bleeding at Skin Graft Donor Sites (Randomized, Single-Blind)

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The rationale underlying the study is that donor site bleeding is common and often problematic when presenting to the burn surgeon or staff. Frequently, gauze wound dressings are not sufficiently hemostatic to control a donor site bleed thereby leading to administration of vasoconstrictive agents and repeated application of wound dressing/pressure. The hemostatic textile Stasilon™ has proven superior to gauze in reducing bleeding from anesthetized pigs undergoing standardized surgically-induced trauma. Also, observational case reports have noted cessation of bleeding in a limited number of human patients with difficult to control bleeds.

Conditions

Interventions

TypeNameDescription
DEVICEStasilonStasilon and gauze will be applied to donor site. Dressings will be collected and evaluated for amount of shed blood.

Timeline

Start date
2008-06-01
Primary completion
2010-09-01
Completion
2010-12-01
First posted
2009-03-04
Last updated
2017-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00855569. Inclusion in this directory is not an endorsement.